Efficacy and safety of Rebamipide in the treatment of dry eye disease: a systematic review and meta-analysis
Authors:
- Mohamed Abo ZeidMZMohamed Abo Zeid
- Amr ElrosasyAEAmr Elrosasy
- Ahmad AlkhederAAAhmad Alkheder
- Raghad SamhaRSRaghad Samha
- Ahmed W. AbbasAAAhmed W. Abbas
- Shrouk F MohamedSMShrouk F Mohamed
- Faisal NaqadanFNFaisal Naqadan
- Hashem Abu SerhanHashem Abu Serhan
Open Access
- 15 January 2026
- journal article
- review article
- Published by Elsevier in JFO Open Ophthalmology
- Vol. 13
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trialScientific Reports, 2024
- Effects of Rebamipide on Differences in Power and Axis of Corneal Astigmatism Between Two Intra-patient Keratometric Measurements in Dry EyesOphthalmology and Therapy, 2021
- A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office WorkersScientific Reports, 2017
- New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye SocietyThe Ocular Surface, 2017
- Comparison of Two Questionnaires for Dry Eye Symptom AssessmentOphthalmology, 2015
- Topical Rebamipide Treatment for Superior Limbic Keratoconjunctivitis in Patients With Thyroid Eye DiseaseAmerican Journal of Ophthalmology, 2014
- A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry EyeOphthalmology, 2013
- Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II StudyOphthalmology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Rebamipide, a Cytoprotective Drug, Increases Gastric Mucus Secretion in Human: Evaluations with Endoscopic Gastrin TestDigestive Diseases and Sciences, 2008